Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Timeline to Accelerated Approval

<< Previous

Bullboard Posts

Next >>

Comment by robertshawon Mar 28, 2022 8:29am

242 Views

Post# 34551221

RE:RE:Timeline to Accelerated Approval

Pandora wrote:
CTI Biopharma (CTIC), the leader in this months Pinnacle Digest stock picking contest, got "Accelerated Approval" for their drug at the end of February and their share price has gone from $1.90 to $5.23

TLD1433 's pending BTD is far more important than CTIC' s AA(which might come in Mid 2025).... But because of Blowjobjoe's bosses inntensive care, we are at dirty cheap level at 0.3 $... Wtf...

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. army